- Manages osteoarthritis of the knee
BIOVISC ORTHO SINGLE 90MG Injection contains Sodium Hyaluronate, a compound that belongs to the class of medications known as viscoelastic supplements. It is specifically formulated to relieve pain associated with knee osteoarthritis, particularly in individuals who have not experienced adequate relief from conventional non-pharmacologic therapies or basic pain relievers.
Sodium hyaluronate is a salt derivative of hyaluronic acid, a naturally occurring substance found in high concentrations within the synovial fluid of healthy joints. This fluid plays a critical role in maintaining joint health by acting as both a lubricant and a shock absorber, allowing smooth and pain-free movement of joints during daily activities such as walking, running, or jumping.
In patients with knee osteoarthritis, the concentration of hyaluronic acid in the synovial fluid is often significantly reduced, leading to increased friction, pain, and joint degeneration. By administering BIOVISC ORTHO SINGLE 90MG directly into the knee joint (intra-articular injection), this deficiency is temporarily corrected. The injected sodium hyaluronate enhances the viscoelastic properties of the joint fluid, providing a cushioning effect and reducing the symptoms of pain and discomfort. It also aids in absorbing the mechanical shocks exerted on the knee during movement, helping to improve joint mobility and quality of life.
This medicine must be administered only by a trained healthcare provider directly into the affected joint. Prior to injection, if there is joint effusion (excess fluid in the joint), it must be drained to improve the effectiveness of the treatment. After receiving the injection, patients are advised to avoid strenuous physical activity or prolonged weight-bearing movements for at least 48 hours, including heavy lifting, running, or high-impact exercise, to ensure optimal absorption and reduce the risk of complications.
Like all injectable medications, BIOVISC ORTHO SINGLE 90MG may cause side effects, most commonly local reactions at the injection site such as joint pain, swelling, redness, or warmth. These symptoms are typically mild and temporary, but if they persist or worsen, it is important to contact your doctor.
This medication is not recommended for use in pregnant or breastfeeding women or in children under 18 years of age due to a lack of sufficient safety data. Before beginning treatment, inform your doctor if you have a history of liver disease or if you currently have an infection or inflammation at or near the intended injection site. Use of this medication in the presence of active joint infections is strictly contraindicated.
Always consult your physician for a proper diagnosis and to determine whether BIOVISC ORTHO SINGLE 90MG is appropriate for your specific medical condition.
